中国卒中杂志 ›› 2020, Vol. 15 ›› Issue (12): 1352-1359.DOI: 10.3969/j.issn.1673-5765.2020.12.016
黄丽红,刘光维
收稿日期:
2019-12-11
出版日期:
2020-12-20
发布日期:
2020-12-20
通讯作者:
刘光维 18523438560@163.com
基金资助:
重庆医科大学附属第一医院2019年度护理科研基金(HLJJ2019-01)
Received:
2019-12-11
Online:
2020-12-20
Published:
2020-12-20
摘要:
急性缺血性卒中静脉溶栓的患者临床预后可受疾病严重程度、发病到溶栓的时间、脑小 血管病、血糖水平、中性粒细胞计数、血小板计数、溶栓后再灌注损伤及出血转化等多种因素的影响。 本文从流行病学、溶栓前后影响缺血性卒中静脉溶栓预后的危险因素及相关预测模型进行文献复习, 旨在加强对缺血性卒中患者静脉溶栓后不良预后危险因素及相关预测模型的认识,为其防治提供理 论依据和临床指导。
黄丽红,刘光维. 缺血性卒中患者静脉溶栓后不良预后危险因素的研究现状[J]. 中国卒中杂志, 2020, 15(12): 1352-1359.
HUANG Li-Hong, LIU Guang-Wei. A Review on Risk Factors Associated with Poor Prognosis after Intravenous Thrombolysis in Ischemic Stroke Patients[J]. Chinese Journal of Stroke, 2020, 15(12): 1352-1359.
[1] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. 2018 guidelines for the early management ofpatients with acute ischemic stroke:a guideline forhealthcare professionals from the American HeartAssociation/American Stroke Association[J/OL].Stroke,2018,49(3):e46-e110[2019-12-11].https://doi.org/10.1161/STR.0000000000000158.[2] 中国老年医学学会急诊医学分会,中华医学会急诊医学分会卒中学组,中国卒中学会急救医学分会. 急性缺血性脑卒中急诊急救中国专家共识2018[J]. 中国卒中杂志,2018,13(9):956-967.[3] 王陇德,刘建民,杨弋,等. 我国脑卒中防治仍面临巨大挑战——《中国脑卒中防治报告2018》概要[J].中国循环杂志,2019,34(2):105-119.[4] EMBERSON J,LEES K R,LYDEN P,et al. Effectof treatment delay,age,and stroke severity on theeffects of intravenous thrombolysis with alteplase foracute ischaemic stroke:a meta-analysis of individualpatient data from randomised trials[J]. Lancet,2014,384(9958):1929-1935.[5] ALI M,FULTON R,QUINN T,et al. How well dostandard stroke outcome measures reflect quality oflife? A retrospective analysis of clinical trial data[J].Stroke,2013,44(11):3161-3165.[6] 国家卫生计生委办公厅,国家中医药管理局办公室.国家卫生计生委办公厅国家中医药管理局办公室关于印发脑卒中综合防治工作方案的通知[R/OL].(2016-12-09)[2019-12-11]. http://www.nhc.gov.cn/jkj/s5879/201612/cef09e0c26744df38fa710d3c0da75ce.shtml.[7] KIDWELL C S,SAVER J L,CARNEADO J,et al.Predictors of hemorrhagic transformation in patientsreceiving intra-arterial thrombolysis[J]. Stroke,2002,33(3):717-724.[8] KHATRI P,KLEINDORFER D O,DEVLIN T,et al. Effect of Alteplase vs aspirin on functionaloutcome for patients with acute ischemic stroke andminor nondisabling neurologic deficits:the PRISMSrandomized clinical trial[J]. JAMA,2018,320(2):156-166.[9] WHITELEY W N,EMBERSON J,LEES K R,etal. Risk of intracerebral haemorrhage with alteplaseafter acute ischaemic stroke:a secondary analysis ofan individual patient data meta-analysis[J]. LancetNeurol,2016,15(9):925-933.[10] LEES K R,BLUHMKI E,VON KUMMER R,etal. Time to treatment with intravenous alteplaseand outcome in stroke:an updated pooled analysisof ECASS,ATLANTIS,NINDS,and EPITHETtrials[J]. Lancet,2010,375(9727):1695-1703.[11] KHATRI P,ABRUZZO T,YEATTS S D,et al.Good clinical outcome after ischemic stroke withsuccessful revascularization is time-dependent[J].Neurology,2009,73(13):1066-1072.[12] MA H,CAMPBELL B C V,PARSONS M W,etal. Thrombolysis guided by perfusion imaging up to9 hours after onset of stroke[J]. N Engl J Med,2019,380(19):1795-1803.[13] PANTONI L,FIERINI F,POGGESI A.Thrombolysis in acute stroke patients with cerebralsmall vessel disease[J]. Cerebrovasc Dis,2014,37(1):5-13.[14] KONGBUNKIAT K,WILSON D,KASEMSAPN,et al. Leukoaraiosis,intracerebral hemorrhage,and functional outcome after acute strokethrombolysis[J]. Neurology,2017,88(7):638-645.[15] IST-3 collaborative group. Association betweenbrain imaging signs,early and late outcomes,andresponse to intravenous alteplase after acuteischaemic stroke in the third International StrokeTrial(IST-3):secondary analysis of a randomisedcontrolled trial[J]. Lancet Neurol,2015,14(5):485-496.[16] CHARIDIMOU A,SHOAMANESH A. Clinicalrelevance of microbleeds in acute stroke thrombolysis:comprehensive meta-analysis[J]. Neurology,2016,87(15):1534-1541.[17] LIU X Y,LI T,DIAO S S,et al. The globalburden of cerebral small vessel disease related toneurological deficit severity and clinical outcomesof acute ischemic stroke after IV rt-PA treatment[J].Neurol Sci,2019,40(6):1157-1166.[18] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. Guidelines for the early management ofpatients with acute ischemic stroke:2019 updateto the 2018 guidelines for the early management ofacute ischemic stroke:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2019-12-11]. https://doi.org/10.1161/STR.0000000000000211.[19] LIN S F,CHAO A C,HU H H,et al. Hyperglycemiapredicts unfavorable outcomes in acute ischemicstroke patients treated with intravenous thrombolysisamong a Chinese population:a prospective cohortstudy[J/OL]. J Neurol Sci,2018,388:195-202[2019-12-11]. https://doi.org/10.1016/j.jns.2018.03.022.[20] OSEI E,FONVILLE S,ZANDBERGEN A,etal. Impaired fasting glucose is associated withunfavorable outcome in ischemic stroke patientstreated with intravenous alteplase[J]. J Neurol,2018,265(6):1426-1431.[21] UCHIMURA I,KAIBARA M,NAGASAWAM,et al. Effect of circulating tissue factor onhypercoagulability in type 2 diabetes mellitusstudied by rheometry and dielectric bloodcoagulometry[J]. Biorheology,2016,53(5/6):209-219.[22] CAPES S E,HUNT D,MALMBERG K,et al.Stress hyperglycemia and prognosis of stroke innondiabetic and diabetic patients:a systematicoverview[J]. Stroke,2001,32(10):2426-2432.[23] BOSHUIZEN M,STEINBERG G K. Stem Cell -based immunomodulation after stroke:effects onbrain repair processes[J]. Stroke,2018,49(6):1563-1570.[24] PEREZ-DE-PUIG I,MIRO-MUR F,FERRERFERRERM,et al. Neutrophil recruitment to thebrain in mouse and human ischemic stroke[J]. ActaNeuropathol,2015,129(2):239-257.[25] LIU H H,WANG R J,SHI J J,et al. Baselineneutrophil counts and neutrophil ratio may predicta poor clinical outcome in minor stroke patientswith intravenous thrombolysis[J/OL]. J StrokeCerebrovasc Dis,2019,28(11):104340[2019-12-11]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104340.[26] MAESTRINI I,STRBIAN D,GAUTIER S,etal. Higher neutrophil counts before thrombolysisfor cerebral ischemia predict worse outcomes[J].Neurology,2015,85(16):1408-1416.[27] GENSICKE H,AL SULTAN A S,STRBIAN D,etal. Intravenous thrombolysis and platelet count[J/OL].Neurology,2018,90(8):e690-e697[2019-12-11].https://doi.org/10.1212/WNL.0000000000004982.[28] KANNAN M,AHMAD F,SAXENA R. Plateletactivation markers in evaluation of thrombotic riskfactors in various clinical settings[J/OL]. BloodRev,2019,37:100583[2019-12-11]. https://doi.org/10.1016/j.blre.2019.05.007.[29] STASZEWSKI J,POGODA A,DATA K,et al.The mean platelet volume on admission predictsunfavorable stroke outcomes in patients treated withIV thrombolysis[J/OL]. Clin Interv Aging,2019,14:493-503[2019-12-11]. https://doi.org/10.2147/CIA.S195451.[30] CHEN S Y,LIN Y S,CHENG Y F,et al. Meanplatelet volume-to-lymphocyte ratio predicts poorfunctional outcomes among ischemic stroke patientstreated with intravenous thrombolysis[J/OL]. FrontNeurol,2019,10:1274[2019-12-11]. https://doi.org/10.3389/fneur.2019.01274.[31] DALKARA T,ARSAVA E M. Can restoringincomplete microcirculatory reperfusion improvestroke outcome after thrombolysis?[J]. J Cereb BloodFlow Metab,2012,32(12):2091-2099.[32] KRAUSE G S,WHITE B C,AUST S D,et al. Braincell death following ischemia and reperfusion:aproposed biochemical sequence[J]. Crit Care Med,1988,16(7):714-726.[33] SIESJO B K. Pathophysiology and treatment of focalcerebral ischemia. Part I:pathophysiology[J]. JNeurosurg,1992,77(2):169-184.[34] WANG X Y,LO E H. Triggers and mediators ofhemorrhagic transformation in cerebral ischemia[J].Mol Neurobiol,2003,28(3):229-244.[35] SUN M S,JIN H,SUN X,et al. Free radicaldamage in ischemia-reperfusion injury:an obstaclein acute ischemic stroke after revascularizationtherapy[J/OL]. Oxid Med Cell Longev,2018,2018:3804979[2019-12-11]. https://doi.org/10.1155/2018/3804979.[36] SEET R C,RABINSTEIN A A. Symptomaticintracranial hemorrhage following intravenousthrombolysis for acute ischemic stroke:a criticalreview of case definitions[J]. Cerebrovasc Dis,2012,34(2):106-114.[37] YAGHI S,WILLEY J Z,CUCCHIARA B,etal. Treatment and outcome of hemorrhagictransformation after intravenous alteplase in acuteischemic stroke:a scientific statement for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2017,48(12):e343-e361[2019-12-11]. https://doi.org/10.1161/STR.0000000000000152.[38] LEES K R,BLUHMKI E,VON KUMMER R,etal. Time to treatment with intravenous alteplaseand outcome in stroke:an updated pooled analysisof ECASS,ATLANTIS,NINDS,and EPITHETtrials[J]. Lancet,2010,375(9727):1695-1703.[39] YAGHI S,BOEHME A K,DIBU J,et al. Treatmentand outcome of thrombolysis-related hemorrhage:amulticenter retrospective study[J]. JAMA Neurol,2015,72(12):1451-1457.[40] STRBIAN D,SAIRANEN T,MERETOJA A,etal. Patient outcomes from symptomatic intracerebralhemorrhage after stroke thrombolysis[J]. Neurology,2011,77(4):341-348.[41] 王茂湘,王晓东,范铁平,等. 急性缺血性脑卒中患者静脉溶栓后出血转化与预后分析[J]. 当代医学,2018,24(21):144-145.[42] 李弘,石秋艳,张春阳,等. 血糖及血糖变异性对急性缺血性脑卒中静脉溶栓预后的影响[J]. 中华老年心脑血管病杂志,2016,18(5):518-521.[43] SHI J,PENG H,YOU S,et al. Increase inneutrophils after recombinant tissue plasminogenactivator thrombolysis predicts poor functionaloutcome of ischaemic stroke:a longitudinal study[J].Eur J Neurol,2018,25(4):645-687.[44] STRBIAN D,MICHEL P,SEIFFGE D J,et al.Symptomatic intracranial hemorrhage after strokethrombolysis:comparison of prediction scores[J].Stroke,2014,45(3):752-758.[45] SUNG S F,CHEN S C,LIN H J,et al. Comparisonof risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenousthrombolysis[J]. Stroke,2013,44(6):1561-1566.[46] LI M,WANG-QIN R Q,WANG Y L,et al.Symptomatic intracerebral hemorrhage afterintravenous thrombolysis in Chinese patients:comparison of prediction models[J]. J StrokeCerebrovasc Dis,2015,24(6):1235-1243.[47] BARBER P A,DEMCHUK A M,ZHANGJ,et al. Validity and reliability of a quantitativecomputed tomography score in predicting outcomeof hyperacute stroke before thrombolytic therapy.ASPECTS Study Group. Alberta Stroke ProgrammeEarly CT Score[J]. Lancet,2000,355(9216):1670-1674.[48] KENT D M,SELKER H P,RUTHAZER R,et al.The stroke-thrombolytic predictive instrument:apredictive instrument for intravenous thrombolysisin acute ischemic stroke[J]. Stroke,2006,37(12):2957-2962.[49] STRBIAN D,MERETOJA A,AHLHELM F J,etal. Predicting outcome of IV thrombolysis-treatedischemic stroke patients:the DRAGON score[J].Neurology,2012,78(6):427-432.[50] SAPOSNIK G,FANG J,KAPRAL M K,et al. TheiScore predicts effectiveness of thrombolytic therapyfor acute ischemic stroke[J]. Stroke,2012,43(5):1315-1322.[51] FLINT A C,FAIGELES B S,CULLEN S P,et al.THRIVE score predicts ischemic stroke outcomesand thrombolytic hemorrhage risk in VISTA[J].Stroke,2013,44(12):3365-3369.[52] FLINT A C,CULLEN S P,FAIGELES B S,et al.Predicting long-term outcome after endovascularstroke treatment:the totaled health risks in vascularevents score[J]. AJNR Am J Neuroradiol,2010,31(7):1192-1196.[53] SEIFFGE D J,KARAGIANNIS A,STRBIAN D,etal. Simple variables predict miserable outcome afterintravenous thrombolysis[J]. Eur J Neurol,2014,21(2):185-191.[54] CAPPELLARI M,TURCATO G,FORLIVESIS,et al. The START nomogram for individualizedprediction of the probability of unfavorable outcomeafter intravenous thrombolysis for stroke[J]. Int JStroke,2018,13(7):700-706.[55] SONG B L,CHEN X L,TANG D,et al. ExternalValidation of START nomogram to predict 3-Monthunfavorable outcome in Chinese acute strokepatients[J]. J Stroke Cerebrovasc Dis,2019,28(6):1618-1622. |
[1] | 鲁燕, 杨保荣, 黄向萍, 杨冠桂, 陈圣文, 李建荣, 曾小明. 县级医院急性缺血性卒中超时间窗经MRI筛选溶栓的病例对照研究 [J]. 中国卒中杂志, 2022, 17(12): 1321-1326. |
[2] | 王恺闻, 卢宝全, 吴秀玲, 马佳丽. 基于MRA评估基底动脉闭塞预后评分预测非重症基底动脉闭塞患者预后效能的研究 [J]. 中国卒中杂志, 2022, 17(12): 1335-1342. |
[3] | 宋彦丽, 林杰, 武一平, 李晓晶, 刘改芬, 夏文静, 张玉英, 张晓林, 吕晨冉, 周红, 李凯, 薛斌, 陈玲玲, 张忠波, 彭晓. 邯郸市居民心脑血管病危险因素的流行现状及高血压知晓率、治疗率和控制率的影响因素研究 [J]. 中国卒中杂志, 2022, 17(12): 1360-1365. |
[4] | 吴娱倩, 张玉梅, 范小伟, 王安心, 逄文斌. 运动想象-动觉治疗对缺血性卒中患者手功能康复效果的研究[J]. 中国卒中杂志, 2022, 17(12): 1366-1371. |
[5] | 吴晓莉, 刘丽旭. 肥胖对卒中预后的影响[J]. 中国卒中杂志, 2022, 17(12): 1391-1395. |
[6] | 伊珞, 周宏宇, 仇鑫, 李子孝, 王拥军. 动脉粥样硬化性疾病的DNA甲基化改变[J]. 中国卒中杂志, 2022, 17(11): 1163-1170. |
[7] | 王誉博, 李子孝, 王拥军. 表观遗传学与缺血性卒中后氧化应激的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1171-1177. |
[8] | 崔凌云, 仇鑫, 周宏宇, 李子孝, 王拥军. DNA甲基化与2型糖尿病的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1183-1188. |
[9] | 邓宇含, 刘爽, 王子尧, 汪雨欣, 刘宝花. 基于结构化数据和机器学习模型预测普通人群卒中发病风险的系统评价和meta分析 [J]. 中国卒中杂志, 2022, 17(11): 1189-1197. |
[10] | 刘光亮, 韩凯月, 苏文龙, 张皓. 不同强度有氧踏车训练对不同病程缺血性卒中患者运动和心肺适能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1203-1208. |
[11] | 胡红梅, 杨磊, 于玲, 秦伟, 白明悦, 胡文立. 急性单发小脑小梗死的临床特征 [J]. 中国卒中杂志, 2022, 17(11): 1221-1226. |
[12] | 徐莹鑫, 张爽, 周晓梅, 袁景林, 赵留庄, 杨海华. 非狭窄性颈动脉斑块与前循环不明原因栓塞性卒中的相关性研究 [J]. 中国卒中杂志, 2022, 17(11): 1233-1237. |
[13] | 付江红, 陈树耿, 束小康, 蒋泽武, 魏栋帅, 贾杰. 脑机接口训练对卒中后感觉障碍患者运动功能恢复的影响:1项探索性研究[J]. 中国卒中杂志, 2022, 17(10): 1051-1057. |
[14] | 程实, 李静, 郭军平, 胡爱香, 于鑫玮, 韩玮, 梁瑛, 张越巍, 冀瑞俊. 急性卒中患者住院期间感染的临床特征及危险因素分析[J]. 中国卒中杂志, 2022, 17(10): 1065-1070. |
[15] | 向薇, 徐璐瑶, 张曼曼, 魏红春, 梁志刚. 缺血性卒中急性期磁敏感加权成像不对称突出静脉征的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(10): 1097-1102. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||